There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global ...
The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...
News-Medical.Net on MSN
Drinking orange juice daily may fine-tune genes tied to cardiovascular wellness
Regular orange juice consumption reprograms immune-cell gene activity linked to blood pressure, lipid metabolism, and ...
Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...
Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...
Here are the top medical news for the dayDaily Orange Juice Consumption May Regulate Genes Linked to Heart Health: Study ...
By procedure type, the preimplantation genetic testing market is divided by procedure type into preimplantation genetic ...
About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...
Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback